Expression of Streptococcus pneumoniae Virulence-Related Genes in the Nasopharynx of Healthy Children

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Sakai, Fuminori ^a   Talekar, Sharmila J ^a   Klugman, Keith P ^a   Vidal, Jorge E ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BACTERIAL RNA;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL DENSITY; CHILD; CODY GENE; COLONY FORMING UNIT; COMD GENE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENE SEQUENCE; GENE TARGETING; HUMAN; LYTA GENE; LYTC GENE; MGRA GENE; NANA GENE; NANB GENE; NASOPHARYNX; NONHUMAN; NUCLEOTIDE SEQUENCE; PAVA GENE; PLY GENE; PSPA GENE; RRGB GENE; STREPTOCOCCUS PNEUMONIAE; UPPER RESPIRATORY TRACT; GENETICS; MICROBIOLOGY; PATHOGENICITY; POLYMERASE CHAIN REACTION; PROCEDURES; VIRULENCE;

ANIMALIA; STREPTOCOCCUS PNEUMONIAE;

CHILD; GENES, BACTERIAL; HUMANS; NASOPHARYNX; POLYMERASE CHAIN REACTION; STREPTOCOCCUS PNEUMONIAE; VIRULENCE;

EID: 84879145729     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067147     Document Type: Article

References (61)

1. Jedrzejas MJ, (2001) Pneumococcal virulence factors: structure and function. Microbiol Mol Biol Rev 65: 187-207.
2. Klugman KP, Madhi SA, Albrich WC, (2008) Novel approaches to the identification of Streptococcus pneumoniae as the cause of community-acquired pneumonia. Clin Infect Dis 47Suppl 3: S202-206.
3. van der Poll T, Opal SM, (2009) Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 374: 1543-1556.
4. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, et al. (2009) Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374: 893-902.
5. Bogaert D, De Groot R, Hermans PW, (2004) Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 4: 144-154.
6. Simell B, Auranen K, Kayhty H, Goldblatt D, Dagan R, et al. (2012) The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines 11: 841-855.
7. Shak JR, Vidal JE, Klugman KP, (2013) Influence of bacterial interactions on pneumococcal colonization of the nasopharynx. Trends Microbiol 21: 129-135.
8. Dunne EM, Smith-Vaughan HC, Robins-Browne RM, Mulholland EK, Satzke C, (2013) Nasopharyngeal microbial interactions in the era of pneumococcal conjugate vaccination. Vaccine 31: 2333-2342.
9. Weiser JN, (2010) The pneumococcus: why a commensal misbehaves. J Mol Med (Berl) 88: 97-102.
10. Watson K, Carville K, Bowman J, Jacoby P, Riley TV, et al. (2006) Upper respiratory tract bacterial carriage in Aboriginal and non-Aboriginal children in a semi-arid area of Western Australia. Pediatr Infect Dis J 25: 782-790.
11. Jounio U, Juvonen R, Bloigu A, Silvennoinen-Kassinen S, Kaijalainen T, et al. (2010) Pneumococcal carriage is more common in asthmatic than in non-asthmatic young men. Clin Respir J 4: 222-229.
12. Adetifa IM, Antonio M, Okoromah CA, Ebruke C, Inem V, et al. (2012) Pre-vaccination nasopharyngeal pneumococcal carriage in a Nigerian population: epidemiology and population biology. PLoS One 7: e30548.
13. Hussain M, Melegaro A, Pebody RG, George R, Edmunds WJ, et al. (2005) A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting. Epidemiol Infect 133: 891-898.
14. Chien YW, Vidal JE, Grijalva CG, Bozio C, Edwards KM, et al. (2013) Density interactions among Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus in the nasopharynx of young Peruvian children. Pediatr Infect Dis J 32: 72-77.
15. Roca A, Hill PC, Townend J, Egere U, Antonio M, et al. (2011) Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial. PLoS Med 8: e1001107.
16. Park HK, Lee HJ, Kim W, (2010) Real-time PCR assays for the detection and quantification of Streptococcus pneumoniae. FEMS Microbiol Lett 310: 48-53.
17. Carvalho Mda G, Tondella ML, McCaustland K, Weidlich L, McGee L, et al. (2007) Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol 45: 2460-2466.
18. Song JH, Dagan R, Klugman KP, Fritzell B, (2012) The relationship between pneumococcal serotypes and antibiotic resistance. Vaccine 30: 2728-2737.
19. Yother J, (2011) Capsules of Streptococcus pneumoniae and other bacteria: paradigms for polysaccharide biosynthesis and regulation. Annu Rev Microbiol 65: 563-581.
20. Rodgers GL, Klugman KP, (2011) The future of pneumococcal disease prevention. Vaccine 29Suppl 3: C43-48.
21. Kadioglu A, Weiser JN, Paton JC, Andrew PW, (2008) The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 6: 288-301.
22. Salha D, Szeto J, Myers L, Claus C, Sheung A, et al. (2012) Neutralizing Antibodies Elicited by a Novel Detoxified Pneumolysin Derivative, PlyD1, Provide Protection against Both Pneumococcal Infection and Lung Injury. Infect Immun 80: 2212-2220.
23. Denoel P, Philipp MT, Doyle L, Martin D, Carletti G, et al. (2011) A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae. Vaccine 29: 5495-5501.
24. Seo SU, Kim JJ, Yang H, Kwon HJ, Yang JY, et al. (2012) Effective protection against secondary pneumococcal pneumonia by oral vaccination with attenuated Salmonella delivering PspA antigen in mice. Vaccine 30: 6816-6823.
25. Vadesilho CF, Ferreira DM, Moreno AT, Chavez-Olortegui C, Machado de Avila RA, et al. (2012) Characterization of the antibody response elicited by immunization with pneumococcal surface protein A (PspA) as recombinant protein or DNA vaccine and analysis of protection against an intranasal lethal challenge with Streptococcus pneumoniae. Microb Pathog 53: 243-249.
26. Moreno AT, Oliveira ML, Ho PL, Vadesilho CF, Palma GM, et al. (2012) Cross-reactivity of antipneumococcal surface protein C (PspC) antibodies with different strains and evaluation of inhibition of human complement factor H and secretory IgA binding via PspC. Clin Vaccine Immunol 19: 499-507.
27. Rolo D, Ardanuy C, Fleites A, Martin R, Linares J, (2009) Diversity of pneumococcal surface protein A (PspA) among prevalent clones in Spain. BMC Microbiol 9: 80.
28. Basset A, Trzcinski K, Hermos C, O'Brien KL, Reid R, et al. (2007) Association of the pneumococcal pilus with certain capsular serotypes but not with increased virulence. J Clin Microbiol 45: 1684-1689.
29. Aguiar SI, Serrano I, Pinto FR, Melo-Cristino J, Ramirez M, (2008) The presence of the pilus locus is a clonal property among pneumococcal invasive isolates. BMC Microbiol 8: 41.
30. Pettigrew MM, Fennie KP, York MP, Daniels J, Ghaffar F, (2006) Variation in the presence of neuraminidase genes among Streptococcus pneumoniae isolates with identical sequence types. Infect Immun 74: 3360-3365.
31. Vidal JE, Ludewick HP, Kunkel RM, Zahner D, Klugman KP, (2011) The LuxS-dependent quorum-sensing system regulates early biofilm formation by Streptococcus pneumoniae strain D39. Infect Immun 79: 4050-4060.
32. Vidal JE, Howery KE, Ludewick HP, Nava P, Klugman KP, (2013) Quorum-sensing systems LuxS/autoinducer 2 and Com regulate Streptococcus pneumoniae biofilms in a bioreactor with living cultures of human respiratory cells. Infect Immun 81: 1341-1353.
33. Joyce EA, Kawale A, Censini S, Kim CC, Covacci A, et al. (2004) LuxS is required for persistent pneumococcal carriage and expression of virulence and biosynthesis genes. Infect Immun 72: 2964-2975.
34. Orihuela CJ, Radin JN, Sublett JE, Gao G, Kaushal D, et al. (2004) Microarray analysis of pneumococcal gene expression during invasive disease. Infect Immun 72: 5582-5596.
35. Oggioni MR, Trappetti C, Kadioglu A, Cassone M, Iannelli F, et al. (2006) Switch from planktonic to sessile life: a major event in pneumococcal pathogenesis. Mol Microbiol 61: 1196-1210.
36. Carvalho Mda G, Bigogo GM, Junghae M, Pimenta FC, Moura I, et al. (2012) Potential nonpneumococcal confounding of PCR-based determination of serotype in carriage. J Clin Microbiol 50: 3146-3147.
37. Lanie JA, Ng WL, Kazmierczak KM, Andrzejewski TM, Davidsen TM, et al. (2007) Genome sequence of Avery's virulent serotype 2 strain D39 of Streptococcus pneumoniae and comparison with that of unencapsulated laboratory strain R6. J Bacteriol 189: 38-51.
38. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
39. O'Brien KL, Bronsdon MA, Dagan R, Yagupsky P, Janco J, et al. (2001) Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies. J Clin Microbiol 39: 1021-1024.
40. Vidal JE, Ohtani K, Shimizu T, McClane BA, (2009) Contact with enterocyte-like Caco-2 cells induces rapid upregulation of toxin production by Clostridium perfringens type C isolates. Cell Microbiol 11: 1306-1328.
41. Laufer AS, Metlay JP, Gent JF, Fennie KP, Kong Y, et al. (2011) Microbial communities of the upper respiratory tract and otitis media in children. MBio 2: e00245-00210.
42. Tettelin H, Nelson KE, Paulsen IT, Eisen JA, Read TD, et al. (2001) Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293: 498-506.
43. Lemon KP, Klepac-Ceraj V, Schiffer HK, Brodie EL, Lynch SV, et al. (2010) Comparative analyses of the bacterial microbiota of the human nostril and oropharynx. MBio 1: e00129-10.
44. Borneman J, Triplett EW, (1997) Molecular microbial diversity in soils from eastern Amazonia: evidence for unusual microorganisms and microbial population shifts associated with deforestation. Appl Environ Microbiol 63: 2647-2653.
45. Trappetti C, Kadioglu A, Carter M, Hayre J, Iannelli F, et al. (2009) Sialic acid: a preventable signal for pneumococcal biofilm formation, colonization, and invasion of the host. J Infect Dis 199: 1497-1505.
46. Parker D, Soong G, Planet P, Brower J, Ratner AJ, et al. (2009) The NanA neuraminidase of Streptococcus pneumoniae is involved in biofilm formation. Infect Immun 77: 3722-3730.
47. Douce G, Ross K, Cowan G, Ma J, Mitchell TJ, (2010) Novel mucosal vaccines generated by genetic conjugation of heterologous proteins to pneumolysin (PLY) from Streptococcus pneumoniae. Vaccine 28: 3231-3237.
48. Pracht D, Elm C, Gerber J, Bergmann S, Rohde M, et al. (2005) PavA of Streptococcus pneumoniae modulates adherence, invasion, and meningeal inflammation. Infect Immun 73: 2680-2689.
49. Charlson ES, Bittinger K, Haas AR, Fitzgerald AS, Frank I, et al. (2011) Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med 184: 957-963.
50. Garcia P, Paz Gonzalez M, Garcia E, Garcia JL, Lopez R, (1999) The molecular characterization of the first autolytic lysozyme of Streptococcus pneumoniae reveals evolutionary mobile domains. Mol Microbiol 33: 128-138.
51. Ferreira DM, Neill DR, Bangert M, Gritzfeld JF, Green N, et al. (2013) Controlled Human Infection and Rechallenge with Streptococcus pneumoniae Reveals the Protective Efficacy of Carriage in Healthy Adults. Am J Respir Crit Care Med 187: 855-864.
52. Sommer F, Kroger R, Lindemann J, (2012) Numerical simulation of humidification and heating during inspiration within an adult nose. Rhinology 50: 157-164.
53. Domenech M, Garcia E, Prieto A, Moscoso M, (2013) Insight into the composition of the intercellular matrix of Streptococcus pneumoniae biofilms. Environ Microbiol 15: 502-516.
54. Eldholm V, Johnsborg O, Haugen K, Ohnstad HS, Havarstein LS, (2009) Fratricide in Streptococcus pneumoniae: contributions and role of the cell wall hydrolases CbpD, LytA and LytC. Microbiology 155: 2223-2234.
55. Guiral S, Mitchell TJ, Martin B, Claverys JP, (2005) Competence-programmed predation of noncompetent cells in the human pathogen Streptococcus pneumoniae: genetic requirements. Proc Natl Acad Sci U S A 102: 8710-8715.
56. Wright AK, Ferreira DM, Gritzfeld JF, Wright AD, Armitage K, et al. (2012) Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage. PLoS Pathog 8: e1002622.
57. McCool TL, Cate TR, Moy G, Weiser JN, (2002) The immune response to pneumococcal proteins during experimental human carriage. J Exp Med 195: 359-365.
58. Simell B, Korkeila M, Pursiainen H, Kilpi TM, Kayhty H, (2001) Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children. J Infect Dis 183: 887-896.
59. Rapola S, Jantti V, Haikala R, Syrjanen R, Carlone GM, et al. (2000) Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media. J Infect Dis 182: 1146-1152.
60. Rubins JB, Duane PG, Charboneau D, Janoff EN, (1992) Toxicity of pneumolysin to pulmonary endothelial cells in vitro. Infect Immun 60: 1740-1746.
61. Rapola S, Kilpi T, Lahdenkari M, Makela PH, Kayhty H, (2001) Antibody response to the pneumococcal proteins pneumococcal surface adhesin A and pneumolysin in children with acute otitis media. Pediatr Infect Dis J 20: 482-487.